| 0 (0%) | 09-27 09:32 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 29.38  |
1-year : | 31.26 |
| Resists | First : | 25.16 |
Second : | 26.77 |
| Pivot price | 24.96 |
|||
| Supports | First : | 22.55 |
Second : | 18.76 |
| MAs | MA(5) : | 24.7 |
MA(20) : | 24.67 |
| MA(100) : | 23.47 |
MA(250) : | 25.83 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 33.1 |
D(3) : | 38.2 |
| RSI | RSI(14): 50.9 |
|||
| 52-week | High : | 35.02 | Low : | 19.05 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ EML ] has closed above bottom band by 35.5%. Bollinger Bands are 0.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 24.73 - 24.9 | 24.9 - 25.04 |
| Low: | 23.77 - 23.95 | 23.95 - 24.1 |
| Close: | 24.34 - 24.62 | 24.62 - 24.85 |
Wed, 24 Sep 2025
EML Payments Appoints Andre Reich as Non-Executive Director - TipRanks
Fri, 12 Sep 2025
WFH mobilizes global community to achieve milestone revisions to WHO EML - PR Newswire
Mon, 08 Sep 2025
EML Realty Partners Announces Sale of Industrial Warehouse in Ft. Pierce, FL - citybiz
Sat, 06 Sep 2025
Bishal Gyawali: The 2025 WHO EML List is Just Out - Oncodaily
Fri, 05 Sep 2025
WHO Includes Popular Anti-Obesity Drugs On Essential Medicines List For Diabetes Control - Health Policy Watch
Fri, 05 Sep 2025
WHO updates list of essential medicines to include key cancer, diabetes treatments - World Health Organization (WHO)
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 6 (M) |
| Shares Float | 5 (M) |
| Held by Insiders | 7.8 (%) |
| Held by Institutions | 73.9 (%) |
| Shares Short | 26 (K) |
| Shares Short P.Month | 33 (K) |
| EPS | 1.78 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 20.4 |
| Profit Margin | -3.3 % |
| Operating Margin | 4.2 % |
| Return on Assets (ttm) | 4.2 % |
| Return on Equity (ttm) | 8.4 % |
| Qtrly Rev. Growth | -3.3 % |
| Gross Profit (p.s.) | 10.49 |
| Sales Per Share | 44.1 |
| EBITDA (p.s.) | 3.56 |
| Qtrly Earnings Growth | -0.2 % |
| Operating Cash Flow | 12 (M) |
| Levered Free Cash Flow | 5 (M) |
| PE Ratio | 13.73 |
| PEG Ratio | 0 |
| Price to Book value | 1.2 |
| Price to Sales | 0.55 |
| Price to Cash Flow | 12.28 |
| Dividend | 0.1 |
| Forward Dividend | 0 |
| Dividend Yield | 0.4% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|